메뉴 건너뛰기




Volumn 160, Issue 3, 2009, Pages 719-720

Phosphodiesterase-5 inhibitors and rosacea: Report of 10 cases

Author keywords

Nitric oxide; Phosphodiesterase 5 inhibitors; Rosacea; Sildenafil; Tadalafil; Vardenafil

Indexed keywords

METRONIDAZOLE; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL; VARDENAFIL;

EID: 60449093774     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.09025.x     Document Type: Letter
Times cited : (11)

References (8)
  • 1
    • 4444315851 scopus 로고    scopus 로고
    • Rosacea: I. Etiology, pathogenesis, and subtype classification
    • Crawford GH, Pelle MT, James W. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004 51 : 327 41.
    • (2004) J Am Acad Dermatol , vol.51 , pp. 327-41
    • Crawford, G.H.1    Pelle, M.T.2    James, W.3
  • 2
    • 38049100849 scopus 로고    scopus 로고
    • Molecular pharmacotherapeutic targeting of PDE5 for preservation of penile health
    • Burnett AL. Molecular pharmacotherapeutic targeting of PDE5 for preservation of penile health. J Androl 2008 29 : 3 14.
    • (2008) J Androl , vol.29 , pp. 3-14
    • Burnett, A.L.1
  • 4
    • 33845592372 scopus 로고    scopus 로고
    • Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: Results from the Erectile Dysfunction Observational Study (EDOS)
    • Morales AM, Haro JM, Beardsworth A et al. Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the Erectile Dysfunction Observational Study (EDOS). Eur Urol 2007 51 : 541 50.
    • (2007) Eur Urol , vol.51 , pp. 541-50
    • Morales, A.M.1    Haro, J.M.2    Beardsworth, A.3
  • 5
    • 33748743368 scopus 로고    scopus 로고
    • Expression, distribution and regulation of phosphodiesterase 5
    • Lin CS, Lin G, Xin ZC, Lue TF. Expression, distribution and regulation of phosphodiesterase 5. Curr Pharm Des 2006 12 : 3439 57.
    • (2006) Curr Pharm des , vol.12 , pp. 3439-57
    • Lin, C.S.1    Lin, G.2    Xin, Z.C.3    Lue, T.F.4
  • 6
    • 34948902222 scopus 로고    scopus 로고
    • Current drug therapy for scleroderma and secondary Raynaud's phenomenon: Evidence-based review
    • Henness S, Wigley FM. Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review. Curr Opin Rheumatol 2007 19 : 611 18.
    • (2007) Curr Opin Rheumatol , vol.19 , pp. 611-18
    • Henness, S.1    Wigley, F.M.2
  • 8
    • 0032411315 scopus 로고    scopus 로고
    • Nitric oxide and its implications in skin homeostasis and disease - A review
    • Bruch-Gerharz D, Ruzicka T, Kolb-Bachofen V. Nitric oxide and its implications in skin homeostasis and disease - a review. Arch Dermatol Res 1998 12 : 643 51.
    • (1998) Arch Dermatol Res , vol.12 , pp. 643-51
    • Bruch-Gerharz, D.1    Ruzicka, T.2    Kolb-Bachofen, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.